Avantor and NIBRT Join Forces to Revolutionize Biopharma Manufacturing

Avantor

RADNOR, PAAvantor, Inc. (NYSE: AVTR) has announced an expanded partnership with the National Institute for Bioprocessing Research and Training (NIBRT) aimed at tackling critical bottlenecks in biopharmaceutical manufacturing. This collaboration focuses on optimizing downstream processes for monoclonal antibodies (mAbs), a key area of growth in personalized medicine.

Avantor will supply a comprehensive range of aseptic fluid handling equipment, including the Masterflex® pump systems and other single-use systems, to NIBRT’s advanced training facilities. These tools are designed to replicate real-world biopharmaceutical production environments, providing trainees with invaluable hands-on experience.

“Monoclonal antibodies have revolutionized medicine by providing personalized treatments for chronic and debilitating conditions,” stated Benoit Gourdier, Executive Vice President and Head of Avantor’s Bioscience Production Segment. He emphasized the importance of optimizing fluid handling to prevent delays and product loss, noting that the partnership with NIBRT equips manufacturers with the necessary technology and expertise to enhance productivity.

The collaboration also includes targeted training sessions developed by Avantor’s bioprocessing experts. These trainings concentrate on improving the efficiency and scalability of mAbs production, leveraging the advanced Masterflex® systems to address scale-up challenges effectively.

Kate Cotter, Director of Training Delivery at NIBRT, highlighted the partnership’s significance, saying, “At NIBRT, we are committed to providing world-class training and expertise to support the biopharma sector. This enhanced partnership with Avantor allows us to further equip the industry with the tools and knowledge necessary to drive innovation and improve efficiency.”

Through this partnership, Avantor and NIBRT aim to prepare the next generation of biopharmaceutical professionals to meet the evolving demands of the industry, ensuring timely and efficient delivery of innovative therapies.

READ:  eMoney Advisor Unveils New Research and Product Roadmap at 2024 Summit

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.